End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 CNY | +0.39% | +2.96% | +10.08% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Appliances, Tools & Housewares
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.08% | 422M | - | ||
+22.79% | 28.64B | C | ||
+35.11% | 6.93B | C+ | ||
+81.37% | 6.43B | - | ||
-22.31% | 5.17B | B- | ||
+0.22% | 3.3B | C- | ||
+28.79% | 3.14B | A | ||
+2.91% | 3.06B | B+ | ||
-0.02% | 3.04B | D | ||
+4.27% | 2.96B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603579 Stock
- Ratings Shanghai Rongtai Health Technology Corporation Limited